Nkarta, Inc.
NKTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001787400
No open-market purchases or sales by Nkarta, Inc. insiders were filed in the last 90 days; 135 institutions reported holding it in 13F filings for Q2 2026, worth $167.9M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Nkarta, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 119
- +8 vs. Q2 2024
- Shares held
- 66.8M
- +4.59M (+7.4%) vs. Q2 2024
- Total value
- $301.7M
- −$65.8M (−17.9%) vs. Q2 2024
- New holders
- 21
- 40 more added
- Sold out
- 13
- 29 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NKTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 135 | $167.9M |
| Q1 2026 | 126 | $121.6M |
| Q4 2025 | 119 | $103.2M |
| Q3 2025 | 120 | $119.4M |
| Q2 2025 | 104 | $96.9M |
| Q1 2025 | 111 | $113.2M |
| Q4 2024 | 112 | $154.8M |
| Q3 2024 | 119 | $301.7M |
| Q2 2024 | 112 | $391.5M |
| Q1 2024 | 115 | $687.1M |
| Q4 2023 | 94 | $270.2M |
| Q3 2023 | 85 | $50.7M |
| Q2 2023 | 97 | $86.5M |
| Q1 2023 | 100 | $147.0M |
| Q4 2022 | 121 | $251.9M |
| Q3 2022 | 105 | $561.5M |
| Q2 2022 | 115 | $536.7M |
| Q1 2022 | 84 | $287.2M |
| Q4 2021 | 92 | $366.5M |
| Q3 2021 | 87 | $651.4M |
| Q2 2021 | 89 | $764.7M |
| Q1 2021 | 97 | $866.8M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Nkarta, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Renaissance Technologies LLC | 884,272 | $4.00M | 0.01% | −28,600−3.1% | Reduced |
| JPMorgan Chase & Co | 1,063,362 | $4.81M | 0.00% | +761,349+252.1% | Added |
| Alyeska Investment Group, L.P. | 1,084,696 | $4.90M | 0.03% | +169,314+18.5% | Added |
| State Street Corp | 1,098,062 | $4.96M | 0.00% | +15,569+1.4% | Added |
| Geode Capital Management, LLC | 1,171,026 | $5.29M | 0.00% | +33,927+3.0% | Added |
| Ameriprise Financial Inc | 1,268,476 | $5.73M | 0.00% | +77,273+6.5% | Added |
| OrbiMed Advisors LLC | 1,480,600 | $6.69M | 0.12% | +680,600+85.1% | Added |
| Wasatch Advisors Inc | 1,834,680 | $8.29M | 0.04% | +442,125+31.7% | Added |
| Deerfield Management Company, L.P. (Series C) | 2,155,000 | $9.74M | 0.15% | −1,644,143−43.3% | Reduced |
| Vanguard Group Inc | 3,009,940 | $13.6M | 0.00% | +53,566+1.8% | Added |
| Citadel Advisors LLC | 3,139,235 | $14.2M | 0.01% | +13,801+0.4% | Added |
| Sr One Capital Management, LP | 3,333,333 | $15.1M | 3.02% | 00.0% | Unchanged |
| NEA Management Company, LLC | 3,568,781 | $16.1M | 0.88% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 3,600,000 | $16.3M | 0.03% | 00.0% | Unchanged |
| Samsara BioCapital, LLC | 3,768,035 | $17.0M | 3.27% | 00.0% | Unchanged |
| Boxer Capital, LLC | 4,029,606 | $18.2M | 0.89% | −1,577,744−28.1% | Reduced |
| BlackRock, Inc. | 4,222,380 | $19.1M | 0.00% | +4,222,380 | New |
| Commodore Capital LP | 4,662,073 | $21.1M | 1.32% | +511,039+12.3% | Added |
| Ra Capital Management, L.P. | 10,805,129 | $48.8M | 0.56% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −135,749−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −68,517−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −67,205−100.0% | Sold out |
| Simplicity Wealth,LLC | 0 | $0 | 0.00% | −37,486−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −35,298−100.0% | Sold out |
| Alpine Global Management, LLC | 0 | $0 | 0.00% | −23,161−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −20,872−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −18,500−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −14,979−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −14,600−100.0% | Sold out |
| Level Four Advisory Services, LLC | 0 | $0 | 0.00% | −12,000−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −2,423−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −73−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |